Cite
HARVARD Citation
Zobel, M. et al. (2020). Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice. Journal for immunotherapy of cancer. 8 (2), p. . [Online].